DoseVault
Metabolic Compound

Liraglutide

Daily GLP-1 analog; FDA-approved for diabetes (Victoza) and obesity (Saxenda).

Scientific Overview

Liraglutide is a once-daily GLP-1 receptor agonist with 97% homology to native GLP-1 plus a fatty-acid linker for albumin binding. Sold as Victoza (T2DM, 2010) and Saxenda (obesity, 2014) by Novo Nordisk. The LEADER trial showed cardiovascular event reduction in T2DM. Now largely displaced by weekly semaglutide.

Key Research Benefits

  • ✓Weight loss ~5-8%
  • ✓HbA1c reduction
  • ✓CV benefit (LEADER trial)

Potential Side Effects

⚠Nausea
⚠Vomiting
⚠Pancreatitis (rare)
⚠Gallbladder events

Research Protocols

Common Dosages

Obesity

0.6 -> 3.0 mg
Daily SC

“Weekly titration”

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

24 Units

or 0.24 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore Liraglutide

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed
    View vendor →

Liraglutide by goal

Read Liraglutide's profile filtered through specific research goals.

Liraglutide for Fat Loss

Molecular Profile

linear
C172H265N43O51
31 AA Sequence

Quick Reference

Status
Research Compound
Category
Metabolic
Common Dosage
0.6 -> 3.0 mg
Daily SC

Strictly for research purposes. Not for human consumption.

Related tools

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.